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Abstract
Background: Prostatic oxidative stress (OS) is androgen-regulated and a key event in the development of prostate cancer
(PC). Thus, reducing prostatic OS is an attractive target for PC prevention strategies. We sought to determine if the
individual’s prostatic OS status can be determined by examining the OS in surrogate androgen regulated tissues from the
same host.
Methodology/Principal Findings: Adult male rats were divided equally into three groups: (A2) underwent bilateral
orchiectomy, (A+) received continuous testosterone supplementation or (C) were eugonadal. Serum testosterone, 8-
hydroxy-2-deoxyguanosine (8-OHdG) and anti-oxidative capacity (AOC) were determined after 72 hrs and the prostate,
salivary glands and the hair follicles’ Dermal Papillary Cells (DPC) from each animal were harvested, embedded into tissue
microarray and examined for the expression of 8-OHdG by immuno-staining. Multi-variate regression was used to analyze
inter-individual differences in OS staining within each androgen group and if there was a correlation between serum
testosterone, 8-OHdG or AOC and Prostatic OS in tissues of same host. At the group level, 8-OHdG staining intensity directly
correlated with serum testosterone levels in all three target tissues (p.0.01, Mann-Whitney Test). Although different levels
of prostatic OS were noted between rats with similar serum testosterone levels and similar systemic OS measurements
(p,0.01), there were no intra-individual differences between the OS status of the prostate and DPC (p,0.05).
Conclusions/Significance: The level of prostatic OS is correlated with the OS of hair follicles and salivary glands, but not
systemic OS. Moreover, systemic AOC negatively correlates with both prostatic and hair follicle OS. This suggests that hair
follicle and salivary gland OS can serve as surrogate markers for the efficiency of OS reduction. This has tremendous
potential for the rational evaluation of patient response to prevention strategies.
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Introduction
Oxidative stress (OS) is a key event in the development of
prostate cancer (PC) [1,2,3], its progression [3,4,5,6] and its
response to therapy [7]. OS is the result of an imbalance between
the production of reactive oxygen species (ROS) and their
detoxification. ROS are inevitable byproducts generated by cell
metabolism and homeostasis, and have been shown to exert
regulatory roles in controlling cell proliferation, survival, and
differentiation [8] However, the accumulation of ROS, a typical
phenomenon of PC [5], triggers a host of pro-carcinogenic
processes. More specifically, increased levels of ROS can cause
oxidative DNA damage. Furthermore, elevated levels of ROS
cause enhanced cell signaling and activation of target genes in PC
cells that promote cellular survival and progression [4,9].
Inflammation induced OS has been associated with prostate
carcinogenesis [5]. Local generation of ROS can be initiated by an
environmental exposure to infectious agents, [1] dietary carcino-
gens, and hormonal imbalances that promote intra-prostatic
inflammatory reactions [10]. Intra-prostatic OS, a phenomenon
regulated via androgen receptor mediated pathways [7], is a prime
target of PC prevention strategies [2,11].
The physiological effects of androgens derive not only from
their serum/tissue levels, but also from interaction with their
receptors and unique activity per individual. The specific effects of
androgens in tissues depend not only on the levels of androgens
and expression of the androgen receptors, but also on individual
variations in the activity of the androgen/androgen-receptor
complex. For example, androgen-regulated activities are attenu-
ated corresponding to the length of triplet CAG residues in the
androgen receptor gene which is subjected to polymorphism [12].
The effect of androgens on OS in target tissues can not be
predicted in an individual simply by measuring circulating
androgen levels.
PC is an attractive candidate for prevention strategies because it
has a high incidence, a protracted latent period and defined risk
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tation in the treatment of PC, recent research has called the
efficacy of such practices into question. Both the Selenium and
Vitamin E Cancer Prevention Trial (SELECT) and the Physician’s
Health Study II showed negative results for vitamin E, vitamin C,
and selenium supplementation on decreasing PC risk [13,14].
Since no individual baseline OS measurements were taken, the
negative results from these studies could reflect the failure of a
mass approach to prevention. Surrogate markers that can predict
an individual’s prostatic OS would complement a more rational-
ized selection of candidates for PC prevention.
The hair follicles and salivary glands are exocrine glands that
express the androgen receptor and share common morphological
characteristics with the prostate [15–18]. We thus hypothesize that
the magnitude of basal OS in these tissues will correlate with that
of the prostate in each individual. In this pre-clinical hypothesis-
generating in-vivo experimental study of male rats, we sought to
demonstrate that the status of prostatic OS correlates with levels in
the hair follicles and the salivary glands of the same subject over
and beyond its androgenic milieu.
Materials and Methods
In-Vivo Studies
After obtaining approval from the Animal Research Ethics
Board at McMaster University (Permit # 08-09-40), eighteen
adult Sprague Dawley male rats (SPF) were purchased from
Charles River Laboratories. Each rat weighed between 200 and
250 grams and was randomized into one of three groups (each
group contained 6 rats). The first group underwent a bilateral
trans-scrotal orchiectomy to induce androgen deficiency and was
labeled ‘‘A2’’ to indicate their lack of endogenous and exogenous
androgens. Each rat in the second group underwent sham trans-
scrotal procedure and sub-cutaneous implantation of a slow
release testosterone pellet (12.5 mg/pellet; Innovative Research
of America, Sarasota, FL). This group was assigned the label
‘‘A+’’ to indicate implantation the presence of excess androgens
(both endogenous and exogenous androgens). The third group
labeled ‘‘C,’’ to indicate this was the control group, underwent
only a sham trans-scrotal operation and thus had no manipula-
tion of the natural endogenous production of testosterone. All
operative procedures described above were performed under
ketamine + xylazine (127.5 and 4.5 mg/kg, respectively) general
anesthesia. All of the animal handling, anesthesia, surgery,
recovery and euthanasia were performed following the Standard
Operating Procedures of McMaster University Central Animal
Facility.
Tissue Preparation
The rats were sacrificed 72 hours after hormone treatment.
Blood was immediately withdrawn from the left ventricle and
separated to serum by centrifugation and freezein-20uC until
analysis. Tissue from the skin, prostate and salivary gland was
immediately removed and fixed in 4% buffered formaldehyde.
Immunohistochemistry
The fixed tissues were embedded in paraffin and then re-
constructed into a pre-planed tissue micro-array (TMA) platform.
Tissue array was made with hand-tissue-arrayer (Beecher
Instruments, Sun Prairie, WI) with the core size set at 2 mm.
The tissue arrays were then pretreated with proteinase K
(DakoCytomation, Glostrup, Denmark) and washed with phos-
phate-buffered saline tween-20 (PBST). Normal Rabbit Serum
diluted in 2% bovine serum albumin (BSA) was used to block the
TMA’s which were subsequently incubated for 30 minutes. The
TMA’s were then incubated with goat anti-8-hydroxy-29-deox-
yguanosine (8-OHdG) antibodies (1:200; Chemicon International)
for one hour. Biotinylated rabbit anti-goat IgG (Vector Labora-
tories, Burlingame, CA) was added for detection purposes and the
TMA’s were incubated for an additional 30 minutes.
Tissue Assay
TMA sections were sequentially put though xylene, 100%
ethanol, 95% ethanol, 50% ethanol and distilled water to
deparaffinize and rehydrate them. Antigen unmasking of the
sections were carried out according to the protocols of the
antibody makers. Immunoreactions of the section were undertak-
en in TBS or TBST buffer after incubation in 3% hydrogen
peroxide for 10 minutes. The non-specific reaction was blocked
with 100–400 ml blocking solution for one hour at room
temperature (5% normal goat or rabbit serum in TBS). The
diluted primary antibody, Biotinylated-secondary antibody, and
ABC reagent were sequentially added, and this was proceeded
with incubation and rinsing with TBS and TBST after each
reaction, in accordance with the manufacturer’s instructions. The
reaction results were visualized with NovaRed Kit (Vector
Laboratories, Burlingame, CA). The sections were dehydrated
and sealed in Permount (Fisher Scientific, Ottawa, Ontario) for
observation. A single pathologist (EF) performed semi-quantative
evaluation based on intensity of cytoplasmatic staining [02 no
stain, 1+ weakly positivity (difficult to see) -3+ (prominent stain)]
and then determined the percentage of positive cells (those with
any degree of staining), as we described before [19]. Accordingly,
the staining intensity index (SII) was calculated as the percent of
positive cells x intensity/100.
Determination of serum testosterone, gAOC, and 8-
OHdG levels
An enzyme-linked immunosorbent assay (ELISA) kit specific to
quantitative measurement of 8-hydroxy-29-deoxyguanosine (Ox-
ford Biomedical, Oxford, Michigan, USA) was used to measure
the serum 8-OHdG levels according to the manufacturers’
instructions. Each sample was tested in triplicate, with the
standard run in duplicate. A portion of the manufacturer’s
provided standard was diluted to a concentration of 1.0 and
5.0 ng/mL in order to best approximate the total concentration of
each sample, as previous test runs indicated that levels of 8-OHdG
were low. Within-assay precision was tested and found to be
greater than 96.6% while edge effects were tested and found to be
negligible. In a similar manner, ELISA was undertaken to test
serum testosterone levels according to the maker’s instructions.
(Alpha Diagnostic International, Cat. No. 1880, San Antonio,
Texas, USA).
To measure serum gAOC, a test was carried out with
BIOXYTECHH AOP-450
TM Colorimetric Quantitative Assay
Kit for Total Antioxidant Potential (Aqueous Samples) by
OxisResearch
TM (Catalog Number: 21053, Beverly Hills, Califor-
nia, USA), according to the manuals of maker.
Data Analysis
A student t-test with a 5% significance level was used to measure
differences is serum gAOC and serum testosterone between the A+
and A2 or C groups. One-Way analysis of variance was used to
identify variance in serum 8-OHdG levels between androgen
groups. A Mann-Whitney test was used to test for significant
differences in staining intensities between treatment groups.
Univariate linear regression was used to measure if increases in
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surrogate tissues. This test was also used to measure if serum AOC
correlated with the OS in the target tissues. Multivariate linear
regression was used to analyze correlations in OS staining
intensities between tissue sites within each individual rat. This
form of analysis was also used to examine if there were inter-
individual differences in OS staining between rats within each
androgen group as well as to examine if there was a correlation
between Prostatic OS and serum 8-OHdG or serum AOC.
Heterogeneity was tested using both a Breusch-Pegan test and a
White test. Data was analyzed by STATA software (Statacorp LP,
College Station, Texas, USA).
Results
The eighteen adult male rats were divided into three treatment
groups. The first group underwent a bilateral trans-scrotal
orchiectomy and was labeled ‘‘A2’’ due to their lack of androgen.
The second group was given testosterone supplementation
through a subcutaneous pellet and was labeled ‘‘A+’’ which
indicated their excess androgens. The last group, ‘‘C’’ had no
change in androgen levels and was thus the control group.
Systemic and tissue (prostate, salivary glands and hair follicles) OS
levels in each rat were measured using 8-OHdG staining and
measuring. The 8-OHdG biomarker was used because the half-life
of reactive oxygen species is extremely short (milliseconds) and
therefore common measurements of OS status are based on the
detection of their more sustained effects on other molecules. Since
this study was conducted with the aim to study the concept of
individualized approaches to prostate cancer prevention we
elected to study a marker for OS induced mutagenesis. Among
ROS-induced forms of DNA damage, 8-OHdG is typical and
most commonly used as a marker for quantitative analysis [20].
As well, systemic AOC and testosterone were measured and
examined.
Androgen effect on OS
Serum testosterone levels of the three treatment groups were
significantly different (p,0.05) with the ‘‘A+’’ rats having the
highest testosterone levels (mean=8 mg/mL, median=8.4 ng/
mL, Tables 1 and 2) and the ‘‘A2’’rats all having castrated levels
(,0.5 ng/mL). This confirmed that we had indeed created groups
with three different levels of androgens: castrated (A2), normal
eugonadal (C) and increased (A+).
Despite these significant differences in serum testosterone levels,
the serum 8-OHdG levels were not significantly different between the
groups (p.0.05, ANOVA test) indicating that androgens do not
affect systemic OS (Figure 1). In contrast, OS levels in the prostate,
salivary glands and DPC showed a positive relationship with serum
testosterone concentration (p.0.05, Mann-Whitney Test; Figure 2).
In all three target tissues, there were statistically significant differences
between the ‘‘A+’’ and ‘‘A2’’ rat groups with regards to 8-OHdG
staining, with the androgen supplemented rats staining more
intensely (p=0.019). The median staining intensity for the hair
follicles of androgen-deprived rats was 1, a much lower grade than
the median for the androgen supplemented rats which was 2. Similar
results were found for the median staining intensities for the hair
follicles and prostate. In both tissues, the ‘‘A+’’ rats had the highest
median staining grades and the ‘‘A2’’ had the lowest. (Tables 1 and 2
& Figure 2) Therefore, it can be deduced that the OS in the three
target tissues increases as the level of androgens in the body increase.
Surprisingly, we discovered that there were inter-individual
differences in 8-OHdG staining intensities between rats with
similar serum testosterone levels (p,0.05). Even in the castrated
rats, which all had almost no serum testosterone (,0.5 ng/mL),
we found that heterogeneity existed between their OS staining
grades in the prostate and surrogate tissues. (Figure 3) These
differences in OS could not be predicted by Serum 8-OHdG
(p,0.05) (Figure 3), thus suggesting that prostatic OS varies
between individuals with similar androgen levels.
Table 1. Experimental data per individual rat.
Androgen Group Rat 1 Rat 2 Rat 3 Rat 4 Rat 5 Rat 6
A+ Serum Testosterone (ng/mL) 8.5 9.2 8.4 5.8 9.69 6.3
Serum 8-OHdG (ng/mL) 3.4 6.0 3.9 2.7 2.0 4.4
Serum gAOC (Relative AOP450) 0.5 1.3 0.5 1.0 1.2 1.5
Prostatic OS Staining Score 2 2 2 2 2 1
DPC OS Staining Score 2.5 1 2 1.5 2 2.5
Salivary Gland OS Staining Score 3 2 2 3 2 1
A2 Serum Testosterone (ng/mL) 0.2 0.2 0.2 0.2 0.2 0.2
Serum 8-OHdG (ng/mL) 3 4.6 4 2.8 4.6 3.6
Serum gAOC (Relative AOP450) 1.3 0.4 0.4 0.7 1.1 0.9
Prostatic OS Staining Score 0 0.5 1 0 1 1.5
DPC OS Staining Score 0.5 0.5 1 0.5 1 1
Salivary Gland OS Staining Score 1 2 1 1 1 1
C Serum Testosterone (ng/mL) 0.8 0.8 0.8 0.7 0.8 0.8
Serum 8-OHdG (ng/mL) 3.5 4.3 2.5 3.5 2.8 1.4
Serum gAOC (Relative AOP450) 1.2 0.6 0.7 0.4 0.5 0.8
Prostatic OS Staining Score 1 2 1.5 1.5 1.5 0.5
DPC OS Staining Score 1 2 2 2 1 2
Salivary Gland OS Staining Score 1 1 1.5 1 2 1.5
Please note the lack of correlation between serum testosterone level and serum 8-OHdG levels and tissue expression of OS.
doi:10.1371/journal.pone.0015880.t001
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After controlling for androgen group and testing a linear
combination of parameters, we found that the DPC were very
effective in predicting the OS of the prostate (p=0.009).
Furthermore, the salivary glands were also found to be
significantly effective in measuring the OS of the prostate
(p=0.001). Our findings purport that the OS of the prostate is
very similar to the OS of the hair follicles and salivary glands in
each individual, and that these tissues may be predictive as
surrogates for the OS status of the prostate.
Relationships between serum anti-oxidative capacity
(AOC) and prostatic OS
Finally, we examined if systemic AOC correlates with OS status
in androgen regulated tissues in general and the prostate in
particular. Unlike systemic OS (as reflected by 8-OHdG levels)
there was a negative correlation between serum AOC levels and
OS stress staining levels in the 3 target tissues (p,0.01). This
implies that systemic manipulation of OS is not only efficient in
reducing prostatic OS, but also OS of the DPC and salivary
glands. The DPC and salivary glands can therefore be used as
surrogate instruments to measure the efficiency of anti-oxidative
PC prevention strategies on an individual basis.
Discussion
Our results indicate that each individual has a unique pattern of
OS in his prostate that is mirrored in his hair follicles and salivary
glands. An individual’s prostatic OS cannot be predicted merely
by serum testosterone levels, as even in the group of castrated rats
inter-individual differences exist (Figure 3). Moreover, the
oxidative capacity in the serum is equal between hosts with wide
differences in their serum testosterone levels (Figure 1) suggesting
that androgens do not affect systemic OS. Therefore, serum
androgen levels and serum OS do not reflect prostatic OS status.
In contrast, the OS in the hair follicles and the salivary glands is
closely correlated with prostatic OS levels.
Hoque et al analyzed the serum levels of protein carbonyl
groups (a marker of OS) in 1,808 PC cases and 1,805 controls
nested in the prostate cancer prevention trail [21]. The study
reported that despite the effect of reduced DHT levels by
Finasteride, there were no significant associations between serum
OS and PC risk. The findings of their study augment our
hypothesis that, with respect to the promoting effects of androgens
on OS in particular, the risk of PC development can not be
predicted by blood measurements of OS related markers.
However, as shown here, OS status in readily available androgen
regulated surrogate tissues such as the hair follicles may accurately
reflect that of the prostate.
The impact of androgens on salivary tissues is thus not limited to
an influence on morphology [22–24], but also includes a broad
spectrum of effects on glandular physiology [25,26]. Androgen
receptors have been identified in the salivary glands of males and
females [27] with a higher concentration of nuclear androgen-
binding sites in males [28]. It has been found that salivary glands
actively up-take androgens from the plasma and rapidly metabolize
them [29]. Indeed, androgens are known to be the primary
mediators of sexual dimorphism in mouse salivary glands.
Accordingly, Andrews and Bullock demonstrated that the enzy-
matic activity of alkaline phosphatase in male salivary glands is
consistently stronger compared to that in female and in control
androgen-insensitive tfm/Y mutant male mice [30]. Furthermore,
several studies have shown that OS markers can be measured in the
saliva [31,32]. In addition to these morphological and physiological
similarities between the salivary glands and prostate, our study
found a close correlation between the OS status of these two tissues.
Androgens act on the hair follicle via the androgen receptor in
dermal papillary cells (DPC). The DPC influence the other cells of
Table 2. Mean, median and range of several factors measured.
Group
Mean, median and range
of serum testosterone (ng/ml)
Mean, median and range
of serum 8-OHdG (ng/ml)
Mean, median and range of
serum gAOC (relative AOP450)
A+ 8.0, 8.5, 5.8–9.69 3.7, 3.6, 2.0–6.0 1.0, 1.1, 0.45–1.46
A2 0.2, 0.2, 0.17–0.24 3.8, 3.8, 2.8–4.6 0.8, 0.8, 0.39–1.32
C 0.8, 0.8, 0.74–0.81 3.0, 3.2, 1.4–4.3 0.9, 0.7, 0.37–1.23
Serum testosterone, 8-OHdG and global anti-oxidative capacity (gAOC) per experimental group. Values were rounded to the nearest tenth for all measurements and
only the ranges are shown with 2 decimal places to show the variation in values.
doi:10.1371/journal.pone.0015880.t002
Figure 1. Serum testosterone (A), anti-oxidative capacity (B), and 8-OHdG levels (c) per treatment group. Results are shown as mean
+/2 S.D. P values were calculated using a two-tailed t-test.
doi:10.1371/journal.pone.0015880.g001
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such as growth factors and/or extracellular matrix components
[33]. It has been shown that the graying hair follicle develops
aging-relating OS and is target by ‘‘anti-aging’’ therapies [34]. A
study by Minelli et al. recently discovered that the prostate also
develops OS as natural part of the aging process [35]. Our study
has found that the OS in these two tissues is similar and suggests
that hair follicles may be able to be used as a surrogate tissue to the
prostate when measuring OS.
Compared to normal subjects or patients with benign prostatic
hyperplasia (BPH), patients with PC have a systemic imbalance in
their OS/antioxidant status [36]. Increased levels of ROS within
the prostate stimulate cell proliferation, induce somatic DNA
mutations and promote genetic instability facilitating the devel-
Figure 2. Oxidative stress in androgen regulated target tissues: Prostate (A&D), salivary glands (B&E) and hair follicles-DPC (C&F).
A–C: Graphs showing the individual staining intensity according to treatment groups (A+: circles, A2: triangles, C: diamonds). Median values are
shown as a line. D–F: Representative 8-OHdG immunostaining under low (640) and high (6400) magnification.
doi:10.1371/journal.pone.0015880.g002
Figure 3. Inter-individual differences and intra-individual similarities in the castrated rats. Inter-individual variability in serum OS and
target tissue 8-OHdG staining in rats with similar (castrated) levels of testosterone.
doi:10.1371/journal.pone.0015880.g003
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effect of environmental factors such as diet and inflammation, we
[7,37] and others [38] have shown that androgens increase the
production of ROS in PC cells. Should the results of those studies
prove robust, the current study has significant potential implica-
tions in the field of PC prevention.
OS may favor the induction of mutagenic processes within the
prostate [39]. Attempts to modulate OS by anti-oxidative
compounds are common practice in PC chemoprevention.
However, the results of the SELECT study demonstrate no
impact of Selenium or Vitamin E on the risk of PC, causing the
termination of the study [13]. A potential explanation for this is
the fact that the chemoprevention protocol, which was aimed to
reduce OS, was not tailored to individuals. There was no
assessment of the baseline prostatic oxidative status of the study
participants before the administration of the compounds or
placebo. Since different individuals have different profiles of OS,
one would expect minimal or no effect of anti-OS compounds in
subjects with lower baseline OS.
Alternatively, application of daily chemoprevention is expected
to be more beneficial and to be accepted with higher compliance
in subjects with high baseline levels of prostatic OS. However,
there is no non-invasive method of determining prostatic OS. The
ability to predict the prostatic OS in chemoprevention candidates
without the need to biopsy the prostate is thus appealing. Recent
research has provided strong evidence to suggest that the saliva
can be used as an assay for several biomarkers. In fact, numerous
studies have measured biomarkers for OS (8-OHdG) and total
anti-oxidative capacity by just using the saliva [40,41]. This would
suggest that since our study has shown that the salivary glands can
be used as surrogate tissue to the prostate, one may predict
prostatic OS by simply testing the saliva without having to biopsy
the gland itself. As well, as mentioned above, the OS of the DPC
can be measured by using the hair follicle. Therefore, a simple
plucking of the hair (as opposed to a skin biopsy) may also be used
to predict prostatic OS. Due to the virtually painless nature of
these diagnostic methods and the potentially large benefit of
obtaining a prostatic OS profile of an individual, we emphasize the
importance of the results of our research and the necessity for
further study.
There are several limitations to the study. Sample size was
small. However, this experiment was designed as a hypothesis-
generating study only and serves as a solid basis for further study in
humans. Another limitation of our study was that, due to the
confines of our experimental model, the rats were not exposed to
other factors that may result in OS of the prostate such as prostatic
inflammation. Individuals exposed to these factors may have
different OS levels in their surrogate tissues; however further study
in humans, who unlike rats have intra-prostatic inflammation, is
necessary to look at this. Lastly, we were unable to monitor rats
over a long period of time and therefore, results reflect only an
acute response to changes in androgen levels.
This hypothesis-generating in vivo study suggests that the
examination of the OS of the DPC of the hair follicles may
provide one with an individual signature of the OS status in the
prostate. Clinical studies are needed to validate these findings in
humans and their potential prognostic implication in the
individualization of PC prevention and therapeutics.
Author Contributions
Conceived and designed the experiments: JHP JL KFW. Performed the
experiments: JHP JL KFW EF AW GP. Analyzed the data: JHP KFW JL
AH GP. Contributed reagents/materials/analysis tools: JHP KFW JL AH.
Wrote the paper: JHP KFW AH LK.
References
1. Klein EA, Casey G, Silverman R (2006) Genetic susceptibility and oxidative
stress in prostate cancer: integrated model with implications for prevention.
Urology 68: 1145–1151.
2. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK (2009) Oxidative stress in
prostate cancer. Cancer Lett 282: 125–136.
3. George J, Nuttall SL, Kendall MJ (2006) Prostate cancer and antioxidants. J Clin
Pharm Ther 26: 231–233.
4. Sung SY, Kubo H, Shigemura K, Arnold RS, Logani S, et al. (2006) Oxidative
stress induces ADAM9 protein expression in human prostate cancer cells.
Cancer Res 66: 9519–9526.
5. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK (2008) Oxidative
stress is inherent in prostate cancer cells and is required for aggressive
phenotype. Cancer Res 68: 1777–1785.
6. Yossepowitch O, Pinchuk I, Gur U, Neumann A, Lichtenberg D, et al. (2007)
Advanced but not localized prostate cancer is associated with increased oxidative
stress. J Urol 178(Pt 1): 1243–1244.
7. Pinthus JH, Bryskin I, Trachtenberg J, Lu JP, Singh G, et al. (2007) Androgen
induces adaptation to oxidative stress in prostate cancer: Implications for
treatment with radiation therapy. Neoplasia 9: 68–80.
8. Behrend L, Henderson G, Zwacka RM (2003) Reactive oxygen species in
oncogenic transformation. Biochem Soc Trans 31: 1441–1444.
9. Shigemura K, Fung SY, Kubo H, Arnold RS, Fujisawa M, et al. (2007) Reactive
oxygen species mediate androgen receptor- and serum starvation-elicited
downstream signaling of ADAM9 expression in human prostate cancer cells.
Prostate 67: 722–731.
10. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gro ¨nberg H, et al. (2007)
Inflammation in prostate carcinogenesis. Nat Rev Cancer 7: 256–69.
11. Myake H, Hara I, Kamidono S, Eto H (2004) Oxidative DNA damage in
patients with prostate cancer and its response to treatment. J Urol 171: 1533.
12. Zitzmann M (2009) The role of the CAG repeat androgen receptor
polymorphism in andrology. Front Horm 37: 52–61.
13. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, et al. (2009)
Effect of selenium and vitamin E on risk of prostate cancer and other cancers:
The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:
39–51.
14. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, et al. (2009)
Vitamins E and C in the prevention of prostate and total cancer in men: The
Physicians’ Health Study II randomized controlled trial. JAMA 301: 52–62.
15. Chen W, Yang CC, Chen GY, Wu MC, Sheu HM, et al. (2004) Patients with a
large prostate show a higher prevalence of androgenetic alopecia. Arch
Dermatol Res 296: 245–249.
16. Jave-Suarez LF, Langbein L, Winter H, Praetzel S, Rogers MA, et al. (2004)
Androgen regulation of the human hair follicle: The type I hair keratin hHa7 is a
direct target gene in trichocytes. J Invest Dermatol 122: 555–564.
17. Inui S, Fukuzato Y, Nakajima T, Kurata S, Itami S (2007) Androgen receptor
co-activator Hic-5/ARA55 as a molecular regulator of androgen sensitivity in
dermal papilla cells of human hair follicles. J Invest Dermatol 127: 2302–2306.
18. Min KW, Gyorkey F (1980)Prostaticadenoma of ductal origin. Urology 16: 95–96.
19. Pinthus JH, Fridman E, Dekel B, Goldberg I, Kaufman-Francis K, et al. (2004)
ErbB2 is a tumor associated antigen and a suitable therapeutic target in Wilms
tumour. J Urol 172: 1644–1648.
20. Floyd RA (1990) The role of 8-hydroxyguanine in carcinogenesis. Carcinogen-
esis 11: 1447–1450.
21. Hoque A, Ambrosone CB, Till C, Goodman PJ, Tangen C, et al. (2010) Serum
oxidized protein and prostate cancer risk within the Prostate Cancer Prevention
Trial. Cancer Prev Res (Phila Pa) 3: 478–483.
22. Jayasinghe NR, Cope GH, Jacob S (1990) Morphometric studies on the
development and sexual dimorphism of the submandibular gland of the mouse.
J Anat 172: 115–127.
23. Sawada K, Noumura T (1991) Effects of castration and sex steroids on sexually
dimorphic development of the mouse submandibular gland. Acta Anat (Basel)
140: 97–103.
24. Cerbon MA, Camacho-Arroyo I, Gamboa-Dominguez A, Gonzalez-Mariscal G
(1996) The rabbit submandibular gland: sexual dimorphism, effects of
gonadectomy, and variations across the female reproductive cycle. J Comp
Physiol [A] 178: 351–357.
25. Sims-Sampson G, Gresik EW, Barka T (1984) Histochemical localization of
ouabain-sensitive, K+-dependent pnitrophenylphosphatase (Na+-K+-ATPase)
activity in the submandibular gland of the mouse: effect of androgen, thyroid
hormone, or postnatal age. Anat Rec 210: 53–60.
Surrogate Tissues for Measuring OS of the Prostate
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e1588026. Mizuki N, Kasahara M (1992) Mouse submandibular glands express an
androgen-regulated transcript encoding an acidic epididymal glycoprotein-like
molecule. Mol Cell Endocrinol 89: 25–32.
27. Laine M, Blauer M, Ylikomi T, Tuohimaa P, Aitasalo K, et al. (1993)
Immunohistochemical demonstration of androgen receptors in human salivary
glands. Arch Oral Biol 38: 299–302.
28. Kyakumoto S, Kurokawa R, Ohara-Nemoto Y, Ota M (1986) Sex difference in
the cytosolic and nuclear distribution of androgen receptor in mouse
submandibular gland. J Endocrinol 108: 267–273.
29. Cefalu WT, Pardridge WM, Chaudhuri G, Judd HL (1986) Serum
bioavailability and tissue metabolism of testosterone and estradiol in rat salivary
gland. J Clin Endocrinol Metabl 63: 20–28.
30. Andrews EJ, Bullock LP (1972) A morphological and histochemical evaluation of
sexual dimorphism in androgen-sensitive pseudohermaphroditic mice. Anat Rec
174: 361–370.
31. Reznick AZ, Shehadeh N, Shafir Y, Nagler RM (2006) Free radicals related
effects and antioxidants in saliva and serum of adolescents with Type 1 diabetes
mellitus. Arch Oral Biol 51: 640–648.
32. Ryo K, Yamada H, Nakagawa Y, Tai Y, Obara K, et al. (2006) Possible
involvement of oxidative stress in salivary gland of patients with Sjogren’s
syndrome. Pathobiology 73: 252–260.
33. Randall VA, Thornton MJ, Hamada K, Messenger AG (1994) Androgen action
in cultured dermal papilla cells from human hair follicles. Skin Pharmacol 7:
20–26.
34. Arck PC, Overall R, Spatz KM, Liezman C, Handjiski B, et al. (2006) Towards
a ‘‘free radical theory of graying’’: Melanocyte apoptosis in the aging human hair
follicle is an indicator of oxidative stress induced tissue damage. FASEB J 20:
1567–1569.
35. Minelli A, Bellezza I, Conte C, Culig Z (2009) Oxidative stress-related aging: A
role for prostate cancer? BBA 1795: 83–91.
36. Arsova-Sarafinovska Z, Eken A, Matevska N, Erdem O, Sayal A, et al. (2009)
Increased oxidative/nitrosative stress and decreased antioxidant enzyme
activities in prostate cancer. Clin Biochem 42: 1228–1235.
37. Lu JP, Monardo L, Bryskin I, Hou ZF, Trachtenberg J, et al. (2010) Androgens
induce oxidative stress and radiation resistance in prostate cancer cells though
NADPH oxidase. Prostate Cancer Prostatic Dis 13: 39–46.
38. Ripple MO, Henry WF, Rao RP, Wilding G (1997) Prooxidant-antioxidant shift
induced by androgen treatment of human prostate carcinoma cells. J Natl
Cancer Inst 89: 40–48.
39. DeWeese TL, Hruzkewycz AM, Marnett LJ (2001) Oxidative stress in
chemoprevention trials. Urology 57: 137–140.
40. Canakc ¸i CF, Canakc ¸i V, Tatar A, Eltas A, Sezer U, et al. (2009) Increased
salivary level of 8-hydroxydeoxyguanosine is a marker of premature oxidative
mitochondrial DNA damage in gingival tissue of patients with periodontitis.
Arch Immunol Ther Exp (Warsz) 57: 205–211.
41. Yasuda M, Ide H, Furuya K, Yoshii T, Nishio K, et al. (2008) Salivary 8-
OHdG:a useful biomarker for predicting severe ED and hypogonadism. J Sex
Med 5: 1482–1491.
Surrogate Tissues for Measuring OS of the Prostate
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15880